Bayer Aktiengesellschaft (BAYRY)

USD 4.92

(-2.19%)

Total Assets Summary of Bayer Aktiengesellschaft

  • Bayer Aktiengesellschaft's latest annual total assets in 2023 was 123.34 Billion EUR , down -1.23% from previous year.
  • Bayer Aktiengesellschaft's latest quarterly total assets in 2024 Q2 was 119.85 Billion EUR , down -0.02% from previous quarter.
  • Bayer Aktiengesellschaft reported annual total assets of 124.87 Billion EUR in 2022, up 3.86% from previous year.
  • Bayer Aktiengesellschaft reported annual total assets of 120.24 Billion EUR in 2021, up 2.73% from previous year.
  • Bayer Aktiengesellschaft reported quarterly total assets of 119.85 Billion EUR for 2024 Q2, down -0.02% from previous quarter.
  • Bayer Aktiengesellschaft reported quarterly total assets of 123.34 Billion EUR for 2023 Q4, up 5.2% from previous quarter.

Annual Total Assets Chart of Bayer Aktiengesellschaft (2023 - 1998)

Historical Annual Total Assets of Bayer Aktiengesellschaft (2023 - 1998)

Year Total Assets Total Assets Growth
2023 123.34 Billion EUR -1.23%
2022 124.87 Billion EUR 3.86%
2021 120.24 Billion EUR 2.73%
2020 117.04 Billion EUR -7.3%
2019 126.25 Billion EUR -0.02%
2018 126.28 Billion EUR 68.18%
2017 75.08 Billion EUR -8.7%
2016 82.23 Billion EUR 11.26%
2015 73.91 Billion EUR 5.24%
2014 70.23 Billion EUR 36.86%
2013 51.31 Billion EUR -0.04%
2012 51.33 Billion EUR -2.71%
2011 52.76 Billion EUR 2.44%
2010 51.5 Billion EUR 0.91%
2009 51.04 Billion EUR -2.8%
2008 52.51 Billion EUR 2.21%
2007 51.37 Billion EUR -8.07%
2006 55.89 Billion EUR 52.31%
2005 36.69 Billion EUR -2.86%
2004 37.77 Billion EUR 1.06%
2003 37.37 Billion EUR -10.42%
2002 41.72 Billion EUR 12.47%
2001 37.1 Billion EUR 1.51%
2000 36.55 Billion EUR 16.86%
1999 31.27 Billion EUR 6.47%
1998 29.37 Billion EUR 0.0%

Peer Total Assets Comparison of Bayer Aktiengesellschaft

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD -22.152%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD -29.619%
CSPC Pharmaceutical Group Limited 6.52 Billion USD -1790.615%
Clarus Therapeutics Holdings, Inc. 51.7 Million USD -238439.491%
Novartis AG 99.94 Billion USD -23.412%
PT Kalbe Farma Tbk. 1.75 Billion USD -6913.195%